BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31277130)

  • 1. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
    Yang J; Chen C; Liu M; Zhang S
    Medicine (Baltimore); 2019 Jul; 98(27):e16214. PubMed ID: 31277130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T; Parikh LI; Ramsey PS; Huang CC; Zeymo A; Fernandez M; Smith S; Iqbal SN
    Am J Obstet Gynecol; 2015 Oct; 213(4):570.e1-8. PubMed ID: 26071912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
    BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A; Maciejewski T; Niemiec KT
    Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
    Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A; Gervasi MT
    Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of maternal bile Acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor.
    Garcia-Flores J; Cañamares M; Cruceyra M; Garicano A; Espada M; Lopez A; Tamarit I
    Gynecol Obstet Invest; 2015; 79(4):222-8. PubMed ID: 25720981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management.
    Wood AM; Livingston EG; Hughes BL; Kuller JA
    Obstet Gynecol Surv; 2018 Feb; 73(2):103-109. PubMed ID: 29480924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B; Özler S
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.
    Roy A; Premkumar M; Mishra S; Mehtani R; Suri V; Aggarwal N; Singh S; Dhiman RK
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):571-576. PubMed ID: 33136720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels.
    Brouwers L; Koster MP; Page-Christiaens GC; Kemperman H; Boon J; Evers IM; Bogte A; Oudijk MA
    Am J Obstet Gynecol; 2015 Jan; 212(1):100.e1-7. PubMed ID: 25046809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Ovadia C; Seed PT; Sklavounos A; Geenes V; Di Ilio C; Chambers J; Kohari K; Bacq Y; Bozkurt N; Brun-Furrer R; Bull L; Estiú MC; Grymowicz M; Gunaydin B; Hague WM; Haslinger C; Hu Y; Kawakita T; Kebapcilar AG; Kebapcilar L; Kondrackienė J; Koster MPH; Kowalska-Kańka A; Kupčinskas L; Lee RH; Locatelli A; Macias RIR; Marschall HU; Oudijk MA; Raz Y; Rimon E; Shan D; Shao Y; Tribe R; Tripodi V; Yayla Abide C; Yenidede I; Thornton JG; Chappell LC; Williamson C
    Lancet; 2019 Mar; 393(10174):899-909. PubMed ID: 30773280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
    Binder T; Salaj P; Zima T; Vítek L
    J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.